1. 29th Annual meeting of the Society for Immunotherapy of Cancer (SITC). Issue 1 (19th May 2015) Authors: Hurwitz, Arthur A; Lee, Sylvia; Knox, Susan; Kohrt, Holbrook; Verdeil, Gregory; Romano, Emanuela; Margolin, Kim; Urba, Walter J; Speiser, Daniel E Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial. Issue 1 (December 2015) Authors: Tan, Amabel; Goubier, Anne; Kohrt, Holbrook Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A. (6th November 2014) Authors: Kowanetz, Marcin; Rabe, Christina; Xiao, Yuanyuan; Wu, Qun J; Koeppen, Hartmut; Leddy, Cecilia; Patel, Rajesh D; Powderly, John; Kohrt, Holbrook; Gettinger, Scott; Soria, Jean-Charles; Herbst, Roy S; Desai, Rupal; Denker, Mitchell; Ruppel, Jane; Boe, Marigold; Nakamura, Rin; Fu, Ling; Sumiyoshi, ... Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells. Issue 2 (December 2015) Authors: Morishima, Chihiro; McNeel, Douglas; Patel, Manish; Kohrt, Holbrook; Waldmann, Thomas; Thompson, John; Conlon, Kevin; Sondel, Paul; Wakelee, Heather; Apodaca, Minjun; Fling, Steven; Disis, Mary; Creekmore, Stephen; Miller, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells. (6th November 2014) Authors: Morishima, Chihiro; McNeel, Douglas G; Patel, Manish R; Kohrt, Holbrook; Waldmann, Thomas A; Thompson, John A; Conlon, Kevin; M Sondel, Paul; Wakelee, Heather; Disis, Mary L; Creekmore, Stephen P; Miller, Jeffrey S Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation. (6th November 2014) Authors: Minev, Boris; Kohrt, Holbrook; Kilinc, Mehmet; Chen, Nanhai; Feng, Audrey; Pessian, Maysam; Geissinger, Ulrike; Haefner, Erik; Tsoneva, Desislava; Bozhilov, Kliment; Sagiv-Barfi, Idit; Zhao, Xing; Rajesekaran, Narendiran; Levy, Ronald; Szalay, Aladar Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein. Issue 2 (December 2015) Authors: Hinner, Marlon; Aiba, Rachida-Siham; Wiedenmann, Alexander; Schlosser, Corinna; Allersdorfer, Andrea; Matschiner, Gabriele; Rothe, Christine; Moebius, Ulrich; Kohrt, Holbrook; Olwill, Shane Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗